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Vinculins interaction with talin is 
essential for mammary epithelial 
differentiation
pengbo Wang1,4, Jian Wu1, Amber Wood  1, Matthew Jones1, Robert pedley  1, Weiping Li1, 
Robert S. Ross  2,3, Christoph Ballestrem1,5, Andrew P. Gilmore  1,5* & charles H. Streuli1,5
Vinculin is an essential component of cell adhesion complexes, where it regulates the strength and 
stability of adhesions. Whilst the role of vinculin in cell motility is well established, it remains unclear 
how vinculin contributes to other aspects of tissue function. Here we examine the role of vinculin 
in mammary epithelial cell phenotype. In these cells, correct adhesion to the extracellular matrix is 
essential for both the formation of polarised secretory acini and for the transcription of tissue-specific 
milk protein genes. We show that vinculin, through its interaction with talin, controls milk protein gene 
expression. However, vinculin is not required for the formation of polarised acini. This work reveals new 
roles for vinculin that are central to cellular differentiation, and for the ability of cells to interpret their 
extracellular microenvironment.
Animal cells constantly interpret their extracellular environment through the interaction between integrins and 
the extracellular matrix (ECM)1. Integrin-containing adhesion complexes control cell behaviours in metazo-
ans, sensing biochemical and mechanical signals within the microenvironment, thereby allowing cells to form 
functioning tissues2. How adhesion complexes convert this extracellular information into complex and varied 
intracellular responses is still unclear. A central question that remains unresolved is how specific components of 
the adhesion complex control physiologically relevant differentiation endpoints.
One of the key proteins involved in sensing mechanical information in adhesion complexes is vinculin3. 
Vinculin is essential for mammalian development, and cells lacking it show diminished adhesion and faster 
migration4–7. Structurally, vinculin consists of a large N-terminal head made up of four separate α-helical bun-
dles (domains D1-D4), a short proline-rich flexible linker, and a C-terminal tail (termed D5)8. The head and tail 
regions interact to form an auto-inhibited inactive conformation, which upon activation opens to allow vinculin 
recruitment to adhesion complexes9,10. In its open conformation, vinculin binds other adhesion complex pro-
teins11. The vinculin D1 region binds to talin whilst D5 interacts with F-actin. Thus, in cooperation with talin, 
vinculin links integrins to the actin cytoskeleton12, acting as a force-sensing clutch in cell-ECM adhesions13.
Most studies involving vinculin provide mechanistic insights into how it regulates cell-matrix adhesion in 
2-dimensional culture models, but it is unclear how vinculin influences tissue-specific function in a 3-dimensional 
(3D) environment similar to in vivo tissue. The ability of mammary epithelial cells (MEC) to form 3D acini that 
differentiate and express tissue-specific genes provides an ideal opportunity for such structure-function analysis. 
Acini require coordination of cell-ECM interactions and endocrine signals from prolactin in order to express 
milk proteins14,15. Deletion of β1-integrin inhibited transcription of milk protein genes in mammary gland secre-
tory acini, both in vivo and in culture16. Furthermore, deletion of β1 integrin prevented MEC from forming 
polarised 3D acini17.
Whilst studies showed that integrins are critical for MEC acini formation, it is not clear how the cytoplasmic 
components of the integrin adhesion complex coordinate the differentiation and polarisation of MEC in 3D. 
Here we show that vinculin has surprisingly little impact on acini formation but does have a critical role in MEC 
differentiation leading to milk production.
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Results
Vinculin is required for MEC differentiation in 3D. To determine how the linkage between integrins 
and the cytoskeleton coordinates MEC differentiation, we isolated primary cells from vinculinfl/fl mice and deleted 
the vinculin gene with adenoviral (Ad)-Cre recombinase (Fig. 1A). Following vinculin deletion, cells were cul-
tured in 3D-matrigel and compared with control cells. Despite a complete loss of vinculin expression, Ad-Cre-
infected vinculinfl/fl MECs form similar size acinar structures in 3D-Matrigel as the uninfected cells (Fig. 1B). 
This result was in marked contrast to when either β1 integrin or ILK are deleted, which leads to the loss of acinar 
integrity16,18. However, despite forming normal sized acini, MECs lacking vinculin failed to differentiate and 
express β-casein when stimulated with prolactin (Fig. 1C).
To verify this finding, we used Eph4 cells, a mouse MEC line which forms polarised acini in 3D and can be 
induced to differentiate and secrete milk proteins by addition of prolactin19. Eph4 cells were infected with a len-
tivirus, pVenus, expressing a vinculin targeting shRNA (hereafter termed shVin). Immunofluorescence imaging 
of shVin-expressing Eph4 cells cultured in 2D showed that they did not have detectable vinculin in adhesions 
(Fig. 1D). We selected stably-infected shVin Eph4 cells by FACS and analysed vinculin expression by quantita-
tive immunoblotting (Fig. 1E). This indicated ~90% knockdown of vinculin expression in the shVin Eph4 cells 
compared to pVenus control cells. As with the AdCre infected vinculinfl/fl cells, shVin Eph4 cells cultured in 3D 
Matrigel formed acini that are indistinguishable by phase contrast microscopy to those formed by cells infected 
with control pVenus (Fig. 1F). In agreement with the data from vinculinfl/fl cells, knockdown of vinculin abolished 
the ability of shVin Eph4 cells to express β-casein in response to prolactin (Fig. 1G). To independently verify the 
effect of vinculin knockdown on milk protein gene expression, we used the lentivirus pGIPZ to stably express a 
vinculin-targeted sh-mir (shVin-mir) in Eph4 cells. These cells formed similar sized acini, showed robust vinculin 
knockdown, but did not express β-casein in response to prolactin (Fig. S1A,B).
Prolactin regulates β-casein gene expression via the phosphorylation of the transcription factor Stat5. Our 
previous studies found that deletion of β1 integrin in MEC inhibits the ability of prolactin to activate Stat516. We 
therefore asked if the effect of vinculin loss on β-casein expression was due to inhibition of Stat5 activation. We 
determined whether or not shVin Eph4 cells show phosphorylation of Stat5 in response to prolactin stimulation. 
In the absence of vinculin, prolactin was unable to activate Stat5, seen by the lack of phosphorylation on tyrosine 
694 (Fig. 1H). In contrast, control pVenus-infected Eph4 cells had clear phosphorylation of Stat5 in response to 
prolactin.
These results show that, as previously seen with β1 integrin, vinculin is necessary for prolactin to activate 
downstream signalling via Stat5, and thereby to permit β-casein gene expression and MEC differentiation.
Loss of vinculin does not inhibit MEC adhesion complex assembly or acinar polarity. The 
requirement of vinculin for the prolactin-mediated expression of milk proteins is similar to the necessity of either 
β1 integrin or ILK16,17. However, deletion of the genes encoding the latter proteins had a detrimental effect on 
the organisation of cell-ECM adhesion complexes in MEC, and resulted in an inability to form polarised acini. 
We therefore asked whether vinculin deletion or knockdown also resulted in any changes in the ECM-adhesion 
complexes.
We first examined the localisation of ILK, phospho-Y397 FAK and phospho-Y31 paxillin by immunofluores-
cence in Eph4 cells grown in 2D (Fig. 2A). Despite the absence of vinculin, immunostaining revealed the presence 
of prominent focal adhesions in shVin-Eph4. Apart from the absence of vinculin, the focal adhesions of shVin 
cells were indistinguishable from uninfected neighbouring cells. To examine potential changes in expression lev-
els of focal adhesion proteins following the loss of vinculin, stable populations of shVin and pVenus control Eph4 
cells were isolated by FACS and grown in 2D. Cell lysates from these cells were immunoblotted for a panel of core 
focal adhesion and signalling components (Fig. 2B). We found that loss of vinculin had no effect on expression 
levels of talin, ILK, FAK, paxillin, Akt or Erk. Furthermore, there was no loss of phosphorylation of FAK, paxillin, 
AKT and Erk in the shVin cells relative to the pVenus control cells. To determine whether vinculin loss alters 
MEC proliferation, Eph4 cells were infected with either pVenus or shVin, grown in 2D and labelled with EdU 
(Fig. 2C). EdU incorporation was quantified in both the GFP positive (infected) and GFP negative (uninfected) 
cells. There were no differences in proliferation between uninfected, infected, pVenus or shVin MECs.
We next asked whether loss of vinculin impairs the organisation of MEC acini and the formation of adhe-
sion complexes in cells cultured in 3D-matrigel. Vinculinfl/fl MEC, either infected with Ad-Cre or uninfected, 
were cultured in matrigel for 10 days before fixing and immunostaining (Fig. 3A). Despite the loss of vincu-
lin, AdCre-infected MEC formed acini that were indistinguishable from uninfected vinculinfl/fl cells, as judged 
by staining for actin, talin and paxillin. To verify these findings, pVenus- and shVin-infected Eph4 cells were 
cultured in matrigel for 10 days before immunostaining for adhesion complex components (Fig. 3B). The 3D 
morphology of vinculin-deficient Eph4 cells was essentially identical to that of control MEC. Furthermore, ILK, 
paxillin and talin all localised to the basal region of the acini in both control and pVenus cells. Phosphorylation 
of FAK (pY397-FAK) and paxillin (pY31-paxillin) was apparent in both control and shVin cells, indicating no 
gross changes in signalling immediately downstream of integrins. Quantification of the basal localisation of talin, 
paxillin, ILK, paxillin-pY31, FAK-pY397 revealed no differences between pVenus and shVin cells (Fig. S2A,B). 
As MEC acinar function and milk protein secretion require correct polarisation, we examined the localisation of 
the tight junction adapter protein, ZO1 (Fig. S2C). Both control and shVin MECs showed an apical/lateral distri-
bution of ZO1, indicating that acini were correctly polarised.
Finally, we determined whether lack of vinculin alters the activation state of β1 integrin on the basal surface of 
the acini. pVenus and shVin Eph4 cells grown in 3D for 10 days were immunostained with mAb 9EG7 (Fig. 3C). 
This antibody recognises the activated (ECM bound) conformation of β1-integrin. ECM-bound β1 integrin was 
detected equally at the basal surface of both vinculin-expressing and vinculin-deficient acini.
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Figure 1. Vinculin expression is required for mammary cells to express milk proteins in 3D-cultures. (A) 
Primary MECs were isolated from 17-day pregnant vinculinfl/fl mice and cultured on collagen-coated dishes 
for 2 days. Cre-mediated depletion of vinculin was achieved by trypsinising, then incubating single cells 
with adenovirus expressing Cre recombinase (AdCre) in suspension for 1 hour at 37 °C. Subsequently either 
untreated or infected cells were cultured in 3D-matrigel for 48 hours. Cells were immunostained for Cre 
and DAPI, indicating that almost all of the MECs were infected with AdCre. Bar = 50 μm. (B) Low-power 
phase-contrast images showing that both the AdCre infected and control primary vinculinfl/fl MECs formed 
identical acini in Matrigel, and were not affected by the addition of prolactin. Bar = 100 μm. (C) Lysates from 
the cells in B. were immunoblotted for vinculin and β-casein. Total Erk was used as a loading control. (D) 
Mammary epithelial Eph4 cells were infected with pVenus-shVin and immunostained for vinculin and Venus 
in 2D. Venus-positive cells did not have detectable vinculin expression. Bar = 20 μm. (E) Venus-positive Eph4 
cells from D. were sorted by FACS and analysed by immunoblotting for vinculin and Erk. On the right side, 
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These results show that vinculin is not required for either integrin adhesion complex assembly or the forma-
tion of acini. Thus, in marked contrast to previous findings for β1 integrin deletion, vinculin deficient MEC have 
no impairment in their ability to organise into polarised 3D acini.
The vinculin head domain is sufficient for MEC differentiation. Vinculin is a multidomain protein 
with individual regions having the capability of interacting with other adhesion complex proteins11. To deter-
mine the contribution of vinculin domains for milk expression, we generated pVenus lentiviral vectors which 
co-expressed both shVin to knockdown endogenous vinculin and either full-length (VinFL) or vinculin dele-
tion constructs. We used chicken vinculin for the rescue constructs, as it was not targeted by shVin. Deletion 
constructs included the vinculin head and neck region (VinN, residues 1–880), or the actin-binding tail (VinC, 
residues 881–1066) (Fig. 4A). These lentiviral constructs were stably transduced into Eph4 cells (Fig. S3A,B).
In 2D culture, VinFL, VinN and VinC localised to focal adhesions, although VinC appeared more cytoplasmic 
(Fig. S3C). When these lines were cultured in 3D, both VinFL and VinN localised strongly at the basal surface of 
the acini, while VinC was more evenly distributed throughout the cell (Fig. 4B). We asked if any of these vinculin 
domains rescued the ability of shVin cells to express β-casein in response to prolactin. Both VinFL and VinN, but 
not VinC, restored β-casein expression of shVin MECs in 3D culture (Fig. 4C). Immunofluorescence showed a 
normal localisation of talin and ILK, indicating that replacing endogenous vinculin with VinFL, VinC or VinN 
had no effect on adhesion complex formation in 3D acini (Fig. 4D).
Vinculin interacts with other adhesion complex proteins, including Arp 2/3, VASP and members of the 
vinexin family, through the flexible proline-rich neck11. By further deleting the neck region from VinN to achieve 
a construct consisting of domains D1-4 (residues 1–838; VinHD; Fig. 4A), we aimed to assess whether any of the 
neck binding proteins have the potential to mediate the response to prolactin. We also tested a construct compris-
ing the N-terminal amino acids (residues 1–258; VinD1; Fig. 4A), which comprises the minimal region to bind 
talin (Fig. 4A). VinD1 has previously been shown to activate the integrin/talin complex leading to the stabilisation 
of focal adhesions in cells cultured in 2D20. As expected, both Venus-tagged VinHD and VinD1 localised to the 
basal surface of acini in 3D Matrigel, and to focal adhesions in cells cultured in 2D on glass (Fig. 4E). The 3D-acini 
were indistinguishable from wild type cells, with talin co-localising with the Venus-vinculin constructs at the 
basal surface (cf. Figu. 4F with Fig. 3). When these acini were treated with prolactin, both VinHD and VinD1 
rescued β-casein expression in shVin cells (Fig. 4G).
These results show that the ability of vinculin’s head region to bind talin is critical for milk protein expression 
in 3D culture. Interactions of vinculin with other binding partners that interact with the neck and tail regions are 
not required.
Vinculin’s requirement for differentiation is not linked to cell-cell adhesion. Vinculin is also 
present at cell-cell adhesions, where it can link cadherins to the actin cytoskeleton via catenins21. Although the 
Venus-vinculin constructs predominantly localise to ECM-junctions, we could not discount a requirement 
for cell-cell junctions in controlling milk protein expression. To address this, we used a single cell assay where 
cadherin-mediated junctions could not be formed.
Primary MEC directly isolated from the mammary glands of mid-pregnant mice, when grown as single cells 
within 3D-matrigel, still respond to prolactin and make β-casein15. To confirm that shVin is able to knock down 
vinculin expression in primary MECs, we infected cells with either pVenus or shVin, and sorted them by FACS 
based on GFP expression. Sorted cells were immediately lysed in sample buffer for immunoblotting (Fig. 5A). 
shVin knocked down vinculin expression in primary MEC to the same extent as in Eph4 cells (cf. Fig. 1E). 
Infected primary cells were then grown as single cells in 3D, and immunostained for GFP and vinculin (Fig. 5B). 
Wild-type and control pVenus-infected MEC had endogenous vinculin located at the cell-matrix interface. In 
contrast, vinculin was absent in shVin-infected cells.
Primary MECs infected and sorted by FACS cannot be grown in culture to obtain sufficient material for 
immunoblotting milk proteins. However, β-casein expression can be determined in MEC at the single cell level by 
immunostaining in 3D15. We transiently infected MEC with the shVin lentivirus and directly quantified β-casein 
expression in infected and uninfected cells within the same population. Primary MECs were infected with pVe-
nus, shVin or VinFL-shVin, embedded as single cells in matrigel, then treated with prolactin. Immunostaining 
was performed to quantify β-casein expression in both the GFP-positive (infected) cells and GFP-negative (unin-
fected) cells (Fig. 5C). Consistent with previous studies15, around 40% of uninfected single MECs stained pos-
itively for β-casein, and this was identical in cells infected with pVenus alone (Fig. 5D). For each condition, the 
level of β-casein expression in the uninfected GFP-negative cells was identical. In contrast, shVin-infected MEC 
showed a significant reduction in the number of single cells expressing β-casein. β-casein expression was rescued 
in shVin cells by the expression of full-length chicken vinculin.
quantitative analysis of the data indicated that vinculin expression was reduced by approximately 90% in 
pVenus-shVin cells, compared with cells infected with pVenus. (F) Mock infected Eph4 cells or those infected 
with shVin-mir were grown in Matrigel for 48 hours, and then treated with prolactin. Phase contrast images (left 
panel) show no difference in acinar appearance. Bar: 100 μm. (G) pVenus and shVin infected Eph4 cells were 
cultured in Matrigel for 48 hours, and then treated with prolactin. Acini were analysed by immunoblotting for 
vinculin, β-casein and Erk. (H) pVenus and shVin infected Eph4 cells were cultured in Matrigel for 48 hours, 
and then treated with prolactin. Acini were analysed by immunoblotting for vinculin, p-Stat5, β-casein and Erk. 
Full-length blots are shown in Supplementary Fig. S4.
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Figure 2. Loss of vinculin expression does not affect cell-ECM adhesions in 2D mammary cell cultures. 
(A) Eph4 cells infected with pVenus-shVin were cultured in 2D and immunostained for vinculin, integrin 
linked kinase (ILK) phopsho-Y397 FAK, phospho-Y31 paxillin and actin to show similar focal adhesions. 
Immunostaining with anti-GFP indicates the pVenus–shVin infected cells. Line plots are shown to indicate 
co-localisation and to compare infected and uninfected cells in the same image. Bars: 20 μm. (B) pVenus 
and pVenus-shVin cells were isolated by FACS. Cells were grown in 2D-culture and lysates probed by 
immunoblotting for the indicated proteins. No significant changes in any of the focal adhesion proteins, or the 
phosphorylation of FAK, Erk, or Akt were seen. Full-length blots are shown in Supplementary Fig. S5. (C) Eph4 
cells infected with pVenus or pVenus-shVin were labelled with EdU before fixing and immunostaining for GFP 
and EdU. The proportion of EdU-positive cells was quantified. There was no effect of vinculin knockdown on 
the number of EdU-positive cells, in three independent experiments. Error bars represent SEM.
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Figure 3. MECs still form polarized acini with correct cell-ECM adhesions in the absence of vinculin. (A) Primary 
MECs isolated from vinculinfl/fl mice were either untreated or infected with adenovirus expressing Cre recombinase 
(AdCre). The cells were cultured in 3D-matrigel and immunostained for vinculin, talin and phosphor-paxillin. Actin 
was stained with phalloidin and nuclei with DAPI. Bars: 10 μm. For quantification of vinculin with talin and pPaxillin 
in both untreated and AdCre treated cells, images were taken using same exposure, the intensity of fluorescence 
per micrometre squared from region of basal side of spheroid were quantified, and the percentage of intensity of 
adhesion proteins in AdCre-treated cells compared to uninfected cells. Note the absence of vinculin does not affect 
the adhesion distribution of talin or pPaxillin. Error bars represent SEM for 3 independent experiments. (B) Eph4 
cells stably infected with either pVenus or shVin were cultured in Matrigel and immunostained for Venus, vinculin, 
paxillin, phosphorylated tyrosine 397 focal adhesion kinase (pY397-FAK), phosphorylated tyrosine 31 paxillin 
(pY31-Paxillin), talin and integrin linked kinase (ILK). Actin was stained with phalloidin and nuclei with DAPI. Bars: 
10 μm. (C) Eph4 cells infected with pVenus or shVin were grown in matrigel, and active β1 integrin was detected 
by immunostaining with the monoclonal antibody 9EG7. Bars: 10 μm. Quantification of 9EG7 staining shows that 
deletion of vinculin doesn’t affect integrin activation, in three independent experiments. Error bars represent SEM.
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Figure 4. Milk protein expression requires the talin binding D1 domain of vinculin. (A) Design of the 
pVenus vinculin shRNA knockdown constructs. For the rescue experiments, the indicated chicken vinculin 
sequences were inserted in frame with the pVenus coding sequence. (B) GFP-immunostaining of Eph4 cells 
in 3D-Matrigel infected with the lentiviral constructs VinN-shVin, VinC-shVin or VinFL-shVin indicates that 
both full-length vinculin and the vinculin N-terminus show strong localization to the basal adhesions, while 
vinculin C-terminus is more cytoplasmic. Bar: 10 μm. (C) Eph4 cells infected with pVenus, shVin, VinFL-
shVin, VinN-shVin or VinC-shVin were grown in Matrigel and either left untreated or treated with prolactin 
for 48 hours. Lysates were immunoblotted for Venus, β-casein or Erk. (D) Eph4 cells expressing VinN, VinC 
or VinFL show no significant alterations in adhesion complexes in 3D matrigel, as seen by immunostaining 
for talin and ILK. Bars: 10 μm. (E) Eph4 cells infected with either VinHD-shVin or VinD1-shVin were grown 
on 2D coverslips (top 2 panels) or in 3D Matrigel (bottom 2 panels). Cells were immunostained for GFP and 
nuclei were stained with DAPI. Bar = 10 μm. (F) VinHD and VinD1 expression in 3D-acinin did not alter the 
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These results show that the ability of vinculin to regulate milk protein expression is independent of cell-cell 
adhesions.
Discussion
In this study we have identified a novel requirement for vinculin in controlling cell-type specific gene expression. 
Vinculin is required for milk protein gene expression, but not for MEC to form polarised acini or to organise 
cell-matrix adhesions in a 3D context. These data indicate that the role of vinculin in sensing the extracellular 
microenvironment in 3D is crucial for some aspects of cell function, but that it is subtler than predicted from 2D 
models of focal adhesion regulation.
The mammary gland is an excellent model for deciphering the role of the ECM in supporting the formation 
and function of 3D tissues2. MEC interactions with laminin within the basement membrane, via β1-integrins, 
are necessary for the prolactin receptor to activate Stat5 and drive milk protein gene expression16. Several studies 
have defined the control of prolactin signalling through integrin in adhesion complexes, using in vivo genetics 
and 3D cell culture models22. Deletion of either β1-integrin or ILK results in the loss of both 3D organisation and 
MEC polarity of MEC acini, along with an inability to express milk in response to prolactin17,18. Whereas Rac1 
can restore milk protein gene expression in ILK-deficient MEC, Rac1 itself is not required for the formation of 
polarised acini23. Thus, integrins appear to initiate multiple signals to coordinate both acinar morphogenesis and 
MEC-specific gene expression. The results presented in this study now indicate that vinculin plays a previously 
unknown role in coordinating tissue-specific gene expression. It is required for prolactin to activate Stat5, but it is 
not necessary for 3D cellular organisation.
Vinculin is found in both cell-ECM and cell-cell adhesions, and it is known that force transmission has dis-
tinct regulatory mechanisms in these contact sites24. We have now discovered that vinculin is only required at 
cell-ECM adhesions for MEC differentiation. A key role of vinculin in adhesion complexes is the transmission 
of mechanical force from the acto-myosin cytoskeleton to the ECM25. In ECM adhesions, vinculin interacts 
with both talin and actin through N- and C-terminal binding sites respectively, and this linkage is required for 
acto-myosin contractility to be transmitted from the ECM6,20. Absence of vinculin, whilst not disrupting focal 
adhesions in 2D, does alter the size and dynamics of adhesion complexes, resulting in altered migration of fibro-
blasts6. In the study presented here, we found no gross change in ECM adhesion complex composition in the 
absence of vinculin in epithelial cells grown in either 2D or 3D. Interestingly, full-length vinculin was not essential 
for milk protein gene expression, and differentiation was rescued in vinculin-deficient cells just by the N-terminal 
talin binding D1 domain. VinD1 lacks the tail region linking it to actin, and therefore it seems that a force trans-
mitting linkage through vinculin is not required for MEC differentiation, although it may have a role in activation 
of full-length vinculin.
How vinculin functions to link adhesion signalling with prolactin signalling remains unclear. One possibility 
is that its role is indirect, through stabilisation of other adhesion complex components. In 2D, the talin-binding 
D1 domain is sufficient to stabilise talin in adhesion complexes, and it can do this independently of acto-myosin 
contractility20. As the talin binding D1 domain of vinculin is sufficient to rescue the expression of milk proteins, 
we can discount roles for other proteins interacting with vinculin, either in the tail or the neck regions. If talin 
binding is all that is required for vinculin to allow MEC differentiation, then it is likely that the adhesion com-
plexes in 3D show a degree of dynamic turnover comparable with FAs in 2D. Furthermore, we can speculate that 
these dynamics are central to how MEC perceive their extrenal microenvironment and respond appropriately 
through downstream signalling. What the signals are remains to be determined, as we found no gross differences 
in FAK or paxillin phosphorylation between vinculin-expressing and -deficient MECs, either in 2D or 3D.
In conclusion, our results demonstrate that vinculin has a crucial role in orchestrating the differentiation of 
epithelia in their normal 3D context. Vinculin does not just have a role in adhesion complex assembly and cell 
migration, but is critically important for the expression of tissue-specific genes5,26. Our data alos reveal that the 
linkage between vinculin and talin is important for its signalling capacity, and highlights novel functions for these 
proteins in epithelial cells.
Methods
Methods are essentially as described in our previous study27.
cell culture. EPH4 cells were derived from spontaneously immortalized mouse mammary gland epithelial 
cells. EPH4 cells were cultured in DF12 medium (BioWhittaker; Lonza) supplemented with 2.5 μg/ml insulin, 
and 5% FCS at 37 °C in a humidified atmosphere of 5% CO2. Primary MECs from were extracted from 19-d 
pregnant vinculinfl/fl28 or WT mice as previously described29, and cultured in growth medium containing 5 μg/ml 
insulin, 1 μg/ml hydrocortisone, 3 ng/ml EGF, 10% FCS, 50 U/ml penicillin/streptomycin, 0.25 μg/ml fungizone, 
and 50 μg/ml gentamycin in F12 medium. All the lentivirus constructs were generated in HEK293T cells cultured 
in DMEM medium supplemented with 10% FCS, as previously described. Note that infecting primary MECs with 
control viruses, e.g. expressing β-gal or LacZ, has no deleterious effect on their expression of adhesion complex 
proteins or milk proteins, or on cell shape in 2D or 3D culture (Naylor et al.16).
basal localization of talin, as seen by immunostaining. Bar = 10 μm. (G) Eph4 cells infected with pVenus, shVin, 
VinHD-shVin or VinD1-shVin were grown in Matrigel and either left untreated or treated with prolactin for 
48 hours. Lysates were immunoblotted for Venus (GFP), β-casein, vinculin or Erk. Full-length blots are shown 
in Supplementary Fig. S6.
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DNA constructs. The lentiviral shRNA vector, pVenus, was provided by Didier Trono (University of Geneva, 
Geneva, Switzerland). shRNA for mouse vinculin was designed with shRNA design tool (Open Biosystems). The 
target sequences for mouse vinculin were the following. shVin: 5′-CGAGATCATTCGTGTGTTA-3′; shVin-mir: 
5′-CGGATTAGAACCAATCTCTTA-3′. A BLAST search did not reveal any other target sequences in mouse. 
Doubled-stranded oligonucleotides were cloned into the lentiviral transfer vectors pVenus (shVin) or pGIPZ 
(shVin-mir).
For the rescue vectors, chicken wild-type vinculin was used to avoid knockdown by the shVin. Chicken and 
mouse vinculin have almost identical amino acid sequences. Full length (aa1-1066), N’-terminus (aa1-880), 
C’-terminus (aa881-1066), head domain (aa1-838) and D1 domain (aa1-259) of vinculin were cloned into pVe-
nus. The expression of Venus (a variant of YFP) tagged rescue proteins were regulated by EF1a promoter, with the 
endogenous vinculin knockdown were achieved by shVin introduced downstream of H1 promoter in the same 
vector.
Lentiviral infection. For lentivirus production, the transfer vectors were co-transfected with the envelope 
plasmid pMD2G and the packaging plasmid psPAX2 into HEK293T cells using PEI reagent. Media were replaced 
after 8–10 h. 10 ml viral supernatant was harvested 48–60 h after transfection, passed through a 0.45-μm filter, and 
further concentrated by centrifugation at 25,000 rpm at 4 °C for 2.5 h. Viral pellets were re-suspended in 0.1 ml 
fresh DF12 medium.
Figure 5. The role of vinculin in regulating milk expression is not dependent upon cell-cell adherens junctions. 
(A) Primary MECs were infected with either pVenus or shVin for 48 hours, then Venus-positive cells were 
sorted by FACS and analysed by immunoblotting for vinculin and Erk. Quantitative analysis of the data 
indicated that vinculin expression was reduced by approximately 80% in shVin cells, compared with cells 
infected with pVenus. (B) Primary MECs, infected with either pVenus or shVin, were plated as single cells in 
Matrigel and immunostained for GFP or vinculin. Immunostaining of individual pVenus cells show localization 
of vinculin at the cell membrane. shVin cells show no detectable vinculin staining. Bars = 1 μm. (C) Single cell 
cultures of primary MECs in Matrigel were treated with prolactin, before cells were immunostained for Venus 
and β-casein. Viral-infected cells were identified by immunostaining for Venus. Bar = 5 µm. (D) The number of 
β-casein positive cells in C. was determined for both the infected (GFP +ve) and uninfected (GFP −ve) cells. 
For each condition, cells were counted in three independent experiments. Bars: 5 μm. Error bars represent SEM.
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Lentiviral infection was performed by adding lentiviral particles directly to pre-cultured 75% confluent cells 
and followed by incubation for 3 h. The infected cells were cultured for 48 h to ensure turnover of pre-existing 
vinculin. Pure populations of infected cells were enriched by FACS sorting the Venus (pVenus) or GFP (pGPIZ) 
positive cells.
Differentiation assay. Cells plated onto basement membrane-matrix (Matrigel BD Biosciences) formed 
3D acini 24 h after plating. Subsequently cells were cultured in differentiation DF12 media containing 5 μg/ml 
insulin and 1 μg/ml hydrocortisone for 48 h. 3 μg/ml prolactin (Sigma) was added and incubated for 48 h for the 
endpoint assays.
For the single cell assay, lentiviral infected primary MECs were trypsinized, passed through a 40 μm filter to 
remove cell aggregates and the remaining single cells were resuspended in Matrigel. 100 μl cell suspension was 
pipetted onto a thin monolayer of Matrigel, set at 37 °C, and cultured in growth medium for 24 h, and then dif-
ferentiation medium containing 5 μg/ml prolactin for a further 48 h. Cells were fixed with 4% formaldehyde in 
PBS and immunostained. Cells were visualized by immunofluorescence, and β-casein expression was quantified 
by nonbiased cell counts.
Immunofluorescence. Cells were fixed with 4% formaldehyde for 10 min, permeabilized for 5 min with 
0.5% Triton X-100 (Sigma-Aldrich), and subsequently incubated for 1 h with primary antibodies and 0.5 h with 
appropriate secondary antibodies (Jackson ImmunoResearch Laboratories, Inc). For actin fluorescence staining, 
Alexa Fluor 647–phalloidin (Invitrogen) was added to cells together with the secondary antibody.
Antibodies used for immunofluorescence: vinculin and talin (Sigma-Aldrich); 9EG7 and paxillin (BD); 
ILK and pPaxillin-Y31 (Cell Signalling); pFAK-Y397 and GFP (Invitrogen); all secondary antibodies (Jackson 
ImmunoResearch Laboratories, Inc.). After staining, coverslips were mounted with antifade reagent (Pro-Long; 
Invitrogen). Mouse anti–β-casein was described previously15.
Mouse anti-ILK was a gift from C.Wu. Commercial primary antibodies were as follows: vinculin, talin 
(Sigma); β1-integrin30; 9EG7 (BD Pharmingen); paxillin (BD transduction labs); phospho-paxillin Y118 and 
phospho-FAK Y397 (Biosource International); V5 and GFP (Invitrogen); Stat5a, Erk (Santa Cruz Biotechnology, 
Inc.). Secondary antibodies were anti-mouse, -rabbit, and –rat cy2 or Rhrx or cy5 (Jackson ImmunoResearch 
Laboratories).
Images of 3D-acinar structure were captured using a Leica TCS SP5 AOBS inverted confocal microscope using 
a ×63 Plan Fluotar objective. Images of 2D-cultured cells were acquired on an Olympus microscope equipped 
with a Deltavision imaging system using either a 100x/1.40 Uplan S Apochromator a 60x/1.42 Plan Apochromat 
objective. Delta vision images were processed by constrained iterative deconvolution using SoftWoRx (Applied 
Precision). All images analysis was performed using ImageJ.
immunoblotting. For immunoblotting, proteins were extracted from cell lysates using NET buffer (50 mM 
Tris-Cl pH 7.6, 150 mM NaCl, 1% NP-40, 2 mM EDTA, 1 mM sodium orthovanadate, 10 mM sodium flu-
oride) supplemented with 1:100 dilution of Protease cocktail inhibitor set 1 (Calbiochem). Equal amounts of 
proteins were separated by SDS -PAGE and immunoblotted for proteins. Specific binding was detected with 
HRP-conjugated secondary antibodies (Jackson laboratories), followed by chemiluminescence (Amersham 
Biosciences). For quantitative analysis of vinculin knockdown, IR labelled secondary antibodies were used 
(Jackson) in conjunction with a LiCor Odyssey imaging system.
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